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Abstract
BACKGROUND—Neural tube defects (NTDs) are considered complex with both genetic and
environmental factors implicated. To date, no major causative genes have been identified in
humans despite several investigations. The first genomewide screen in NTDs (Rampersaud et al.
2005) demonstrated evidence of linkage to chromosomes 7 and 10. This screen included forty-four
multiplex families and consisted of 402 microsatellite markers spaced approximately 10 cM apart.
Further investigation of the genomic screen data identified a single large multiplex family,
pedigree 8776, as primarily driving the linkage results on chromosome 7.
METHODS—To investigate this family more thoroughly, a high-density single nucleotide
polymorphism (SNP) screen was performed. Two-point and multipoint linkage analyses were
performed using both parametric and nonparametric methods.
RESULTS—For both the microsatellite and SNP markers, linkage analysis suggested the
involvement of a locus or loci proximal to the telomeric regions of chromosomes 2q and 7p, with
both regions having nonparametric lod* scores of ~3.0, yielding very similar evidence in favor of
linkage.
CONCLUSIONS—The regions of strongest evidence for linkage map proximal to the telomeres
on these two chromosomes. In addition to mutations and/or variants in a major gene, these loci
may harbor a microdeletion and/or translocation; potentially, polygenic factors may also be
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involved. This single family may be promising for narrowing the search for NTD susceptibility
genes.
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Introduction
Neural Tube Defects: Clinical Impact
Birth defects are the leading cause of death for neonates in the United States; the risk of an
infant being born with significant congenital abnormality in body structure or function is
~3-4%. Neural tube defects (NTDs) occur at a rate of 1 per 1000 live births in the United
States (Campbell et al. 1986; Lary and Edmonds 1996), representing both the most common
congenital malformation of the central nervous system and the second most common type of
birth defect. Neural tube closure occurs during the first three to four weeks of development.
NTDs are due to failure of closure of the neural tube during early embryogenesis, typically
before a woman is aware of her pregnancy. NTDs can present clinically with large
phenotypic variation. The most common presentations are spina bifida (spina bifida cystica,
open spina bifida) and anencephaly. These phenotypes represent the classic definition of
NTDs and whether they are caused by the same underlying genetic basis remains
controversial.
NTDs can frequently be disabling. Children affected with spina bifida often undergo surgery
to close the defect within 48 hr after birth, and may require frequent surgical intervention for
complications such as hydrocephalus. Affected patients commonly have an impaired ability
to walk and often need to use a wheelchair, and they may have little or no bowel and/or
bladder control. Severely affected NTD cases may require aggressive surgical, medical, and
rehabilitative care. Thus, for a child and their family affected with an NTD, the psychosocial
and emotional tolls are immeasurable. These significant medical and personal costs have
lead to several collaborative studies to investigate NTDs to better understand the genetic and
environmental etiologies.
Evidence for genetic and environmental components
NTDs are caused by a complex interaction between genetic and environmental risk factors.
Several exogenous risk factors are correlated with the development of NTDs, including
maternal insulin-dependent diabetes mellitus, obesity, maternal use of anti-epileptic
(valproic acid), and and maternal consumption of the mycotoxin fumonisin (Gomez 1981;
Bjerkedal et al. 1982; Lindhout and Schmidt 1986; Shaw et al. 1996; Watkins et al. 1996;
Marasas et al. 2004; Loeken 2005). An important environmental intervention for NTDs is
periconceptional supplementation with folic acid, which has been shown to reduce the
recurrence risk for NTDs by reducing the recurrence risk for NTDs by 50-70% (Milunsky et
al. 1991; MRC Vitamin Study Research Group 1991; Centers for Disease Control and
Prevention 1992). However, folate supplementation has not entirely eliminated the risk of
NTDs, suggesting that there are additional underlying genetic factors that may contribute to
the development of NTDs.
Stamm et al. Page 2






















Several lines of evidence support a genetic component to NTDs (Frey and Hauser 2003).
The most compelling evidence for a genetic factor is the higher recurrence risk for NTDs
among offspring from parents with previous NTD pregnancies (Carter 1974; Copp and
Bernfield 1994). Notably, the NTD recurrence risk for siblings is 2-5%, representing a 25-50
fold increased risk above that observed in the general population (Khoury and Wagener
1995). NTDs are also associated with established genetic syndromes including Meckel-
Gruber syndrome, anterior sacral meningomyelocele, anal stenosis, trisomies 13 and 18, and
other chromosomal aberrations (Hume et al. 1996; Kennedy et al. 1998; Lynch 2005).
Furthermore, a plethora of mouse models with mutations leading to NTDs have been
identified (Greene and Copp 2005). Overall, these observations support a genetic component
to the development of NTDs.
Initial genomic screen results
Results from the first genome screen of NTDs were recently reported (Rampersaud et al.
2005). This screen included 44 multiplex families and considered 402 microsatellite markers
with approximate 10 cM spacing. The genomic screen identified regions of interest on
chromosomes 7 and 10, with the highest lod score of 2.45 on chromosome 7 using
parametric linkage analysis. Further investigations of the genomic screen data identified a
single large family 8776, a multigenerational Caucasian family with lumbosacral
myelomeningocele segregating, as primarily driving the linkage results on chromosome 7.
Additionally, this family revealed a region on chromosome 2 with evidence in favor of
linkage (unpublished data).
In this study of family 8776, the microsatellite genomic screen was followed up with a
whole-genome high-density SNP screen to confirm the previously identified region on
chromosomes 7 and 2 and narrow the minimum candidate interval for each. In addition, the
SNP screen could identify previously unidentified regions of linkage. The utility of SNPs
over microsatellites for genomewide screens has been validated, with studies demonstrating
increases in information content with SNP screens being dependent on family structure,
previous marker density, and other factors (Evans and Cardon 2004; Middleton et al. 2004;
John et al. 2004; Schaid et al. 2004). However, this increased density comes at a cost:
simulation-based studies have lead to concern regarding inter-marker linkage disequilibrium
(LD) in dense SNP-genomic screens. These simulations demonstrated that dense SNP data
can cause false positive elevation of multipoint lod scores, especially in the presence of
missing parental genotypes (Huang et al. 2004; Boyles et al. 2005).
Materials and Methods
Clinical data collection and power analysis
NTD family 8776 was identified by self-referral through the NTD Collaborative Study.
First-degree relatives and relatives connecting related affected individuals were ascertained
in this extended family. A detailed family history (Melvin et al. 1998) was obtained and
medical records including operative reports and pre-surgical x-ray films were collected for
review of diagnosis by a neurosurgeon (TMG). Of the affected individuals in the pedigree,
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three were diagnosed with lumbosacral myelomeningocele and a fourth individual was
diagnosed with congenital dermoid cyst with tethered cord.
Certified phlebotomists obtained blood samples from affected individuals and related family
members at medical centers, clinics, or by visiting participants’ homes. Some participants
sent in mailer kits with their enclosed samples. This study was conducted under the
oversight of Duke University Medical Center Institutional Review Board and informed
consent was obtained from all participants.
Power analysis of family 8776, under the broad phenotypic classification, was performed for
the microsatellites screen by using the program SIMLINK (Boehnke 1986; Ploughman and
Boehnke 1989). The assumptions for the power studies included an autosomal dominant
inheritance pattern with low penetrance (affecteds-only) model, a disease allele frequency of
0.001, and a marker with 75% heterozygosity linked at 5% recombination with the disease
allele. These power studies generated an average parameric lod score for family 8776 at a
recombination fraction θ = 0.05 of 1.063 ± 0.02 and a maximum lod score of 2.515. These
power estimations are based on 2-point parametric analysis with a specified dominant mode
of inheritance; therefore this analysis may underestimate power to detect linkage when using
a high-density SNP approach.
Genotyping methods
Blood samples were collected on 4 affected individuals and 27 unaffected individuals in
family 8776. DNA was extracted from whole blood using the Puregene system (Gentra
Systems, Minneapolis, MN). Whole genome SNP typing was performed using the
Affymetrix 10K SNP Chip (Affymetrix, Santa Clara, CA). In brief, the 10K SNP Chip
requires only 250 ng of genomic DNA and yields genotypes for ~10,644 SNPs from the
SNP Consortium database with an average heterozygosity of 0.37, and covering on average
~1 SNP every 210 kb. Microarrays were scanned by using the GeneChip Scanner 3000
according to the manufacturer’s protocol (Affymetrix). Data acquisition was performed by
using the GeneChip GCOS software.
Whole genome linkage analyses
The integrity of the family’s pedigree structure was confirmed as previously reported
(Rampersaud et al. 2005) using data generated from the genomewide microsatellite screen
with the program RELPAIR (Boehnke and Cox, 1997; Epstein et. al., 2000).
All marker information from the genomic screen was databased using the PEDIGENE
system (Haynes et al. 1995). Data were evaluated for Mendelian inconsistencies using
PedCheck (O’Connell and Weeks, 1998). Markers were retained in the map files for linkage
analysis if they demonstrated at least 85% efficiency. Allele frequencies for the SNP
markers were estimated based on 126 unrelated Caucasian individuals that were genotyped
on the 10K SNP chip. Map order for the SNP markers was generated from sequence data
provided by Translational Genomics (Phoenix, AZ). To account for potential inter-marker
LD in the dense SNP screen, LD Select was used (Carlson et al. 2004) with pairwise r2 >
0.16 (Boyles et al. 2005) to generate map files that contained only tagging SNPs.
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Linkage analysis was performed using the program Allegro (Gudbjartsson et al. 2000) for
both 2-point and multipoint analysis. Because the exact inheritance pattern of NTDs is
unknown, different analytic approaches were applied to these data, including parametric
(assuming dominant inheritance and a disease allele frequency of 0.001) and nonparametric
analysis. For the nonparametric analysis, an identity-by-descent relative pair sharing method
lod* was assessed between all pairs of affected individuals using Spairs (Whittemore and
Halpern 1994) and the exponential model (Kong and Cox, 1997) as implemented in Allegro.
Since the unaffected individuals in the pedigree 8776 could represent asymptomatic gene
carriers or have undiagnosed NTDs, a low penetrance affecteds-only parametric model was
applied such that unaffected individuals contributed no information to the lod score other
than to infer missing genotypic data on unsampled individuals. Size limitations in Allegro’s
computational capability allowed inclusion of only 24 individuals from family 8776 in the
linkage analyses, so the least informative individuals were eliminated from the analysis.
Phenotypic criteria included both broad (all 6 affected individuals) and narrow (only 5
affected individuals with lumbosacral myelomeningocele), with the narrow phenotypic
definition excluding individual 100, who has a congenital dermoid cyst. The 2 affected
individuals 102 and 1075 who were not sampled were included in the analyses, because the
genotypic information on their siblings and/or parents using maximum-likelihood estimation
techniques can help to infer the affected individual’s missing genotypes.
To confirm segregation of a disease-linked haplotypes within regions of interest, haplotype
analysis was performed using both visual inspection and a statistical approach with Simwalk
(Weeks et al., 1995).
Sequencing of Candidate Genes
Several genes mapping to the regions of interest were identified using an internally
developed bioinformatics tool Genominator2 that operates via Ensembl (Xu et al., 2002).
Primers were designed using Primer 3 (http://frodo.wi.mit.edu/cgi-bin/primer3/
primer3_www.cgi) on genomic sequence from UCSC’s database (http://genome.ucsc.edu/).
Primers were designed to flank the exons and include the splicing region to account for
splice variants. PCR products covered all the exons and respective intronic boundaries. PCR
product was purified using Sephadex G-50 fine (Amersham Biosciences, Piscataway, NJ)
and QuickStep2 SOPE Resin (Edge BioSystems, Gaithersburg, MD). Samples were
sequenced using the BigDye Terminator v3.1 Cycle Sequencing Ready Reaction kit
(Applied Biosystems, Foster City, CA) and purified using Sephadex G-50 fine. Both
forward and reverse strands were sequenced. The sequence data was analyzed to evaluate
for putative polymorphisms using ABI 3100 Data Collection Software Version 1.01 and
ABI Sequencing Analysis 3.7. All sequences for candidate genes MEOX-2 and FZD7 were
visually inspected with this software to evaluate noteworthy variants such as a premature
termination codon, a frameshift mutation(s) or a missense mutation(s). The sequence data
were compared to unaffected parents to ascertain if a variant was transmitted or a de novo
mutation.
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Linkage Results for Family 8776—The individuals included in the linkage analyses
using Allegro are indicated in Figure 1. The regions of interest were defined by a one lod
unit drop support interval from the peak lod to approximate 95% confidence intervals. Table
1 summarizes the linkage findings for the SNP data based on the results from Allegro
multipoint lod scores > 2.5 and with two-point lod scores ≥ 1.8; plots for these regions are
shown in Figure 2. The strongest evidence for linkage occurred near the telomeres of
chromosomes 7 (7p21.1-pter) and 2 (2q33.1-q35). Specifically, the maximum multipoint
nonparametric lod* score was 3.01 on chromosome 2 in the region spanning rs1379007-
rs1992235. For chromosome 7, the maximum multipoint nonparametric lod* score was 2.99
in the region spanning rs2353788-rs1368215. These results provide an approximate 10%
increase in information content over the maximum multipoint scores in the microsatellite
genomic screen.
When individual 100, who has a closed NTD, was included as affected (under the broad
phenotype), her genotypic information increased the overall lod score under both parametric
and nonparametric analyses.
Haplotyping
Preliminary haplotyping using Simwalk (Weeks et al. 1995) and hand-haplotyping
confirmed the linkage regions identified in Table 1. The haplotype results are consistent
with autosomal dominant transmission with reduced penetrance. Individual 100, who has the
closed NTD variant of congenital dermoid cyst, also carried the disease-associated
haplotypes on chromosomes 2 and 7. Visual inspection of marker data for chromosome 2
expanded the candidate interval to span markers D2S1776 to D2S1363 approximating a 55.2
cM region. For chromosome 7, marker coverage of 7pter extended only to the middle of
7p22.3; as a result, the flanking marker for the 7pter end of the disease-associated haplotype
could not be determined. Thus, the minimum candidate interval for chromosome 7 spans
from D7S3051 to 7pter approximating a 32.3 cM region. The presumed unaffected
individual 126 carried the chromosome 7 disease-associated haplotype and showed a
crossover between D7S2201 and D7S641. If individual 126 is truly “unaffected,” the
crossover could reduce the minimum candidate interval to 17.4 cM.
Candidate genes
Several biologically plausible candidate genes reside in the regions of interest defined by
haplotyping results. Using Ensembl (http://www.ensembl.org/index.html), a list of candidate
genes for chromosomes 2 and 7 was assembled for mutational analysis. For chromosome 2,
the frizzled 7 receptor (FZD7) gene that maps to 2q33.1 was sequenced. Members of the
frizzled gene family encode 7-transmembrane domain proteins that are receptors for Wnt
signaling proteins. The highly conserved Wnt-frizzled signal non-canonical transduction
pathways have been shown in several animal models to be involved in convergent extension,
the process that leads to elongation of the neural plate during neural tube development
(Wallingford and Harland, 2002; Lawrence and Morel, 2003; Copp et al., 2003). Human
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mesenchyme homeobox 2 (MEOX 2), located at 7p21.3-p22.1, is a homeobox gene involved
in formation, patterning, and differentiation of somites. The mouse homolog Meox-2 is
required for migration of limb bud and null Meox-2 mice have decreased limb muscle mass
and demonstrate downregulation of Pax3 (Mankoo et al., 2003). Both genes evaluated
(FZD7 and MEOX-2) did not show any novel genetic polymorphisms.
Discussion
For some complex diseases, traditional linkage analysis approaches in rare families with
Mendelian or near-Mendelian inheritance patterns has identified susceptibility loci. For
example, investigators who studied rare multigenerational families with early-onset fully
penetrant Alzheimer’s disease identified linkage to chromosome 14 and subsequently
identified the amyloid precursor protein (APP) gene (Tanzi and Bertram, 2001). Later
investigations identified a second locus and the genetic risk gene presenilin 1 (PSEN 1)
(Tanzi and Bertram, 2001). Other examples using single large families to identify linkage
regions that influence disease susceptibility include familial focal segmental
glomerulosclerosis (Winn et al. 2005), coronary artery disease (Wang et al., 2003), dementia
(Ashley-Koch et al., 2005), tonic-clonic seizure (Puranam et al., 2005) sensoineural hearing
loss (Blanton et al., 2002; Tlili et al., 2005), among others. This focused approach of genetic
analysis is advantageous for minimizing genetic heterogeneity, thereby increasing the
investigator’s ability to identify areas of allele sharing in large multiplex families.
Using a high-density SNP genomic screen, linkage of Family 8776 was confirmed for the
previously reported locus at 7p21.1- pter. Additionally, a locus at 2q33.1-q35 yielded
increased evidence in favor of linkage over that from the earlier microsatellite genomic
screen (Rampersaud et al., 2005). These two regions of interest exhibit similar statistical
support for an NTD susceptibility locus, which may reflect multiple distinct genetic effects.
Haplotype analysis verified these regions of interest and demonstrated that the high-risk
haplotypes segregate in a pattern consistent with autosomal dominant inheritance and
reduced penetrance, or alternatively, an environmental factor that triggers disease
presentation. As with any genetic linkage study, these results could represent a spurious
finding.
An avenue for further investigation involves more precise phenotypic definition in the
presumptively unaffected individuals. For instance, determining whether these unaffected
individuals have subtle dysraphic changes such as spina bifida occulta may stimulate
broadening of the NTD phenotype, increase the power for future linkage analyses, enhance
the ability to minimize a candidate interval, and identify individuals at high risk to conceive
a pregnancy with an NTD. Alternatively, the failure to identify radiographic changes in
presumptively unaffected “transmitting” individuals may reflect a non-penetrant allele or a
susceptibility locus in the absence of an eliciting environmental insult. Studies to elucidate
the phenotype involve radiographic confirmation by x-ray and/or magnetic resonance
imaging and may be difficult to obtain in a research setting due to increased risk to the
subject. Any detected differences in affected individuals’ NTD phenotype from family 8776
may potentially be explained by pleiotropic effects of a common underlying gene, different
genetic backgrounds containing a modifier gene, and/or different environmental exposures
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at a critical developmental time point. Two individuals in family 8776 demonstrate the
importance of accurate phenotypic definition.
For instance, when individual 100, who has an NTD variant of congenital dermoid cyst, was
included in the analyses as affected, the lod scores for the 7p and 2q regions were increased.
Individual 100 also carries the same high-risk haplotype as other affected individuals with
lumbosacral myelomeningocele in the family.
And, haplotype analysis also revealed that individual 126, who appears phenotypically
unaffected, to be recombinant for the disease-associated chromosome 7 haplotype. Since
individual 126 is a minor, radiographic studies are not available for clarification of the
phenotype. If individual 126 demonstrated no evidence for a radiographic abnormality, the
7p interval could potentially be narrowed by 14.9 cM to a 17.4 cM region between
D7S641-7pter. However, this crossover for the unaffected individual should be interrupted
cautiously because she may harbor a subtle dysraphic variant which would lead to a change
in her affection status, thereby modifying the minimum candidate interval.
Several promising candidate genes reside in the regions of interest for chromosomes 2 and 7.
FZD7, CASP8, CASP10, PAX3, and a cluster of HOXD genes map to the region of interest
on 2q. MEOX2 and TWIST1 genes map to 7p. Sequence data for FZD7 and MEOX2 genes
did not reveal any potential causal variants for this family; however, the promoter regions
for these genes have yet to be evaluated. In addition to evaluation of candidate genes, family
8776 is also under investigation for potential chromosomal abnormalities using both
comparative genomic hybridization (CGH)-arrays and fluorescent in situ hybridization
(FISH).
Overall, the highest linkage results for family 8776 map near the telomeric regions of
chromosomes 2 and 7. Telomeric regions typically are difficult to map due to limited marker
density, and in fact, the chromosome 7 region of interest could be narrowed with an
increased marker density. Regions proximal to the telomeres tend to have a high degree of
interchromosomal recombination, so it is plausible that a microdeletion and/or translocation
event has taken place in one or both of these regions. Chromosomal abnormalities are
associated with NTDs, and reports suggest 2-16% of non-syndromic NTDs have detectable
cytogenetic abnormalities (Lynch, 2005). The 2q region of interest for family 8776 includes
the PAX3 gene, for which an interstitial de novo microdeletion of 2q35-q36.2 has been
previously reported for two patients with Waardenburg syndrome type III and
myelomeningocele (OMIM 148820) (Nye et al., 1998). PAX3 is a member of the Paired Box
transcription factor gene family that has been extensively studied for its role in early
development. Pax3 is expressed in the mouse neural tube and mutant Pax3 mice (Splotch)
embryos have neural tube defects, including spina bifida and exencephaly, (the equivalent of
human anencephaly).
Focusing on rare Mendelian-like families for linkage studies can identify susceptibility loci
that may later be shown to alter risk in the non-Mendelian forms of the disease. Family
8776, as one of the largest reported NTD families, may represent an important resource for
narrowing the search for NTD candidate genes since it provides a unique opportunity for
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identification of a single major locus. However, evaluation of this one family may or may
not be generalizable to all NTDs, so any putative high-risk haplotypes, genetic variant(s)
and/or chromosomal abnormalities may or may not be unique to this family. Consequently,
any results identified in family 8776 must be characterized in other families to determine
generalizability.
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Pedigree diagram of family 8776: Condensed version of extended family 8776. Fully shaded
symbols represent individuals affected with lumbosacral myelomeningocele. The half
shaded circle for individual 100 represents congenital dermoid cyst. The quarter shaded
circle denotes the 5 individuals who are affected by history alone. + indicates sampled
(DNA) individuals. § refers to individuals included in linkage analysis. Individuals 102 and
1075 are reported to have lumbosacral myelomeningocele; however, the medical records
and radiographic studies are not currently available to confirm this diagnosis.
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Multipoint lod score curves for regions of interest on chromosome 2 (A) and chromosome 7
(B). Both SNP and microsatellite marker linkage results using parametric and nonparametric
linkage methods are plotted. The total genetic distance covered by the analyzed markers is
given on the x axis in cM.
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